0001237899-20-000023.txt : 20200609
0001237899-20-000023.hdr.sgml : 20200609
20200609160530
ACCESSION NUMBER: 0001237899-20-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200609
DATE AS OF CHANGE: 20200609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L
CENTRAL INDEX KEY: 0001225474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20951853
MAIL ADDRESS:
STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS
STREET 2: 5323 HARRY HINES BLVD
CITY: DALLAS
STATE: TX
ZIP: 75390
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-06-08
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001225474
GOLDSTEIN JOSEPH L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2020-06-08
4
M
0
3000
413.33
A
9643
D
Common Stock
2020-06-08
4
M
0
3000
413.33
A
12643
D
Common Stock
2020-06-08
4
M
0
4838
413.33
A
17481
D
Common Stock
2020-06-08
4
S
0
100
580.65
D
17381
D
Common Stock
2020-06-08
4
S
0
200
582.31
D
17181
D
Common Stock
2020-06-08
4
S
0
1175
583.67
D
16006
D
Common Stock
2020-06-08
4
S
0
200
585.58
D
15806
D
Common Stock
2020-06-08
4
S
0
300
587.2
D
15506
D
Common Stock
2020-06-08
4
S
0
3200
587.88
D
12306
D
Common Stock
2020-06-08
4
S
0
200
589.87
D
12106
D
Common Stock
2020-06-08
4
S
0
100
590.47
D
12006
D
Common Stock
2020-06-08
4
S
0
60
592.46
D
11946
D
Common Stock
2020-06-08
4
S
0
700
595.31
D
11246
D
Common Stock
2020-06-08
4
S
0
1111
596.47
D
10135
D
Common Stock
2020-06-08
4
S
0
771
597.51
D
9364
D
Common Stock
2020-06-08
4
S
0
200
598.07
D
9164
D
Common Stock
2020-06-08
4
S
0
200
600.12
D
8964
D
Common Stock
2020-06-08
4
S
0
400
601.29
D
8564
D
Common Stock
2020-06-08
4
S
0
1196
602.7
D
7368
D
Common Stock
2020-06-08
4
S
0
525
603.82
D
6843
D
Common Stock
2020-06-08
4
S
0
200
604.49
D
6643
D
Non-Qualified Stock Option (right to buy)
413.33
2020-06-08
4
M
0
3000
0.0
D
2025-01-02
Common Stock
3000
7838
D
Non-Qualified Stock Option (right to buy)
413.33
2020-06-08
4
M
0
3000
0.0
D
2025-01-02
Common Stock
3000
4838
D
Non-Qualified Stock Option (right to buy)
413.33
2020-06-08
4
M
0
4838
0.0
D
2025-01-02
Common Stock
4838
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $581.98 to $582.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,175 shares of Company stock on June 8, 2020 at prices ranging from $583.15 to $584.11. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $585.75 to $585.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on June 8, 2020 at prices ranging from $586.80 to $587.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 3,200 shares of Company stock on June 8, 2020 at prices ranging from $587.88 to $587.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $589.41 to $590.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 700 shares of Company stock on June 8, 2020 at prices ranging from $594.86 to $595.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,111 shares of Company stock on June 8, 2020 at prices ranging from $595.91 to $596.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 771 shares of Company stock on June 8, 2020 at prices ranging from $597.04 to $597.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $599.66 to $600.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 400 shares of Company stock on June 8, 2020 at prices ranging from $600.85 to $601.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,196 shares of Company stock on June 8, 2020 at prices ranging from $602.15 to $603.00. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 525 shares of Company stock on June 8, 2020 at prices ranging from $603.25 to $604.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $604.40 to $604.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**Joseph L. Goldstein
2020-06-09